Literature DB >> 10653399

Pulmonary hypertension associated with pulmonary occlusive vasculopathy after allogeneic bone marrow transplantation.

M Seguchi1, N Hirabayashi, Y Fujii, Y Azuno, N Fujita, K Takeda, Y Sato, M Nishimura, K Yamada, Y Oka.   

Abstract

BACKGROUND: Pulmonary vasculature abnormalities, including pulmonary veno-occlusive disease, have been demonstrated in marrow allograft recipients. However, it is often difficult to make a correct diagnosis of pulmonary lesions.
METHODS: An open lung biopsy was performed on a patient who developed severe pulmonary hypertension after bone marrow transplantation for T-cell lymphoma.
RESULTS: An open lung biopsy specimen demonstrated pulmonary arterial occlusion due to intimal fibrosis and veno-occlusion. The most striking alteration was partial to complete occlusion of the small arteries by fibrous proliferation of the intima.
CONCLUSION: High-dose preparative chemotherapy and radiation before transplantation are thought to have contributed to the development of vasculopathy in this patient, because arterial occlusion by intimal fibrosis and atypical veno-occlusion are often associated with lung injury due to chemoradiation. An open lung biopsy is essential for diagnosing pulmonary vascular disease presenting signs compatible with posttransplantation pulmonary hypertension.

Entities:  

Mesh:

Year:  2000        PMID: 10653399     DOI: 10.1097/00007890-200001150-00030

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Pulmonary veno-occlusive disease: a misnomer?

Authors:  Cindy R Miller
Journal:  Pediatr Radiol       Date:  2012-02-05

2.  Pulmonary veno-occlusive disease in a pediatric hematopoietic stem cell transplant patient: a cautionary tale.

Authors:  M S Zinter; A Melton; A J Sabnis; C C Dvorak; B M Elicker; H M Nawaytou; R J Kameny; J R Fineman
Journal:  Leuk Lymphoma       Date:  2017-09-28

3.  Increased tricuspid regurgitant jet velocity by Doppler echocardiography in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study.

Authors:  Gregory T Armstrong; Vijaya M Joshi; Liang Zhu; Deokumar Srivastava; Nan Zhang; Kirsten K Ness; Dennis C Stokes; Matthew T Krasin; James A Fowler; Leslie L Robison; Melissa M Hudson; Daniel M Green
Journal:  J Clin Oncol       Date:  2013-01-07       Impact factor: 44.544

4.  Increased Mutagen Sensitivity and DNA Damage in Pulmonary Arterial Hypertension.

Authors:  Chiara Federici; Kylie M Drake; Christina M Rigelsky; Lauren N McNelly; Sirena L Meade; Suzy A A Comhair; Serpil C Erzurum; Micheala A Aldred
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

Review 5.  Hematological disorders and pulmonary hypertension.

Authors:  Rajamma Mathew; Jing Huang; Joseph M Wu; John T Fallon; Michael H Gewitz
Journal:  World J Cardiol       Date:  2016-12-26

6.  Pulmonary Veno-Occlusive Disease: A Rare Cause of Pulmonary Hypertension.

Authors:  Said Hajouli; Muhamad Alhaj Moustafa; Jessica S Wang Memoli
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 7.  Myeloid-Derived Suppressor Cells and Pulmonary Hypertension.

Authors:  Andrew J Bryant; Borna Mehrad; Todd M Brusko; James D West; Lyle L Moldawer
Journal:  Int J Mol Sci       Date:  2018-08-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.